Kanagawa, Japan

Ayaka Akutagawa

This inventor holds 3 USPTO granted patents and 5 published patent applications. Top assignee: Terumo Kabushiki Kaisha. Active years: 2016-2018.

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ayaka Akutagawa: Innovator in Medical Treatments

Introduction

Ayaka Akutagawa is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of medical treatments, particularly in addressing chronic obstructive pulmonary disease and tissue fibrosis. With a total of 3 patents to her name, her work is recognized for its innovative approaches to complex health issues.

Latest Patents

One of her latest patents is a lung volume reduction method. This treatment method provides a reliable therapeutic effect on chronic obstructive pulmonary disease. The method involves reducing lung volume by restraining the expansion and contraction of lung parenchyma near the verge of a lung affected by emphysema. Another notable patent is related to a fibrosis-causing agent, which is highly effective in inducing fibrosis in tissues. This agent contains both a fibrosis inducer and a fibrosis promoter, along with a dosage form and a method for its administration.

Career Highlights

Ayaka Akutagawa is associated with Terumo Kabushiki Kaisha, a leading company in the medical technology sector. Her work at Terumo has allowed her to focus on developing innovative solutions that address critical health challenges.

Collaborations

She collaborates with talented individuals such as Yuichi Tada and Suguru Hata, contributing to a dynamic team that drives innovation in medical treatments.

Conclusion

Ayaka Akutagawa's contributions to medical technology through her patents highlight her role as a key innovator in the field. Her work continues to impact the lives of many individuals suffering from chronic health conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…